DVA vs. FMS

Last updated Apr 1, 2026

Compare and contrast key facts about DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS).

Performance

DVA vs. FMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). The values are adjusted to include any dividend payments, if applicable.

DVA vs. FMS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DVA DaVita Inc.	35.28%	-24.03%	42.75%	40.30%	-34.36%	-3.10%	56.47%	45.80%	-28.78%	12.54%
FMS Fresenius Medical Care AG & Co. KGaA	-5.29%	8.11%	11.86%	30.88%	-48.42%	-20.28%	14.76%	15.62%	-37.60%	25.49%

Fundamentals

Market Cap DVA : $13.54B FMS : $12.90B
EPS DVA : $9.14 FMS : $1.68
PE Ratio DVA : 16.82 FMS : 13.40
PEG Ratio DVA : 3.12 FMS : 0.49
PS Ratio DVA : 0.92 FMS : 0.67
Total Revenue (TTM) DVA : $13.28B FMS : $19.63B
Gross Profit (TTM) DVA : $4.21B FMS : $5.03B
EBITDA (TTM) DVA : $2.71B FMS : $3.34B

Returns By Period

In the year-to-date period, DVA achieves a 35.28% return, which is significantly higher than FMS's -5.29% return. Over the past 10 years, DVA has outperformed FMS with an annualized return of 7.59%, while FMS has yielded a comparatively lower -4.68% annualized return.

DVA

• 1D: 0.87%
• 1M: -1.67%
• YTD: 35.28%
• 6M: 15.67%
• 1Y: 0.47%
• 3Y*: 23.74%
• 5Y*: 7.83%
• 10Y*: 7.59%

FMS

• 1D: 1.58%
• 1M: -3.84%
• YTD: -5.29%
• 6M: -14.32%
• 1Y: -6.90%
• 3Y*: 4.83%
• 5Y*: -6.94%
• 10Y*: -4.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DVA vs. FMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVA

DVA Risk / Return Rank: 41
DVA Sharpe Ratio Rank: 42
DVA Sortino Ratio Rank: 38
DVA Omega Ratio Rank: 37
DVA Calmar Ratio Rank: 44
DVA Martin Ratio Rank: 44

FMS

FMS Risk / Return Rank: 31
FMS Sharpe Ratio Rank: 31
FMS Sortino Ratio Rank: 27
FMS Omega Ratio Rank: 27
FMS Calmar Ratio Rank: 35
FMS Martin Ratio Rank: 35

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVA vs. FMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DVA	FMS	Difference
Sharpe ratio Return per unit of total volatility	0.01	-0.24	+0.25
Sortino ratio Return per unit of downside risk	0.31	-0.13	+0.44
Omega ratio Gain probability vs. loss probability	1.04	0.98	+0.06
Calmar ratio Return relative to maximum drawdown	0.07	-0.23	+0.30
Martin ratio Return relative to average drawdown	0.14	-0.41	+0.56
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DVA vs. FMS - Sharpe Ratio Comparison

The current DVA Sharpe Ratio is 0.01, which is higher than the FMS Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of DVA and FMS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DVA	FMS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.01	-0.24	+0.25
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.22	-0.22	+0.44
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.23	-0.16	+0.39
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	0.12	+0.19

Correlation

The correlation between DVA and FMS is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DVA vs. FMS - Dividend Comparison

DVA has not paid dividends to shareholders, while FMS's dividend yield for the trailing twelve months is around 3.49%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DVA DaVita Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
FMS Fresenius Medical Care AG & Co. KGaA	3.49%	3.30%	2.80%	2.97%	4.34%	2.57%	1.72%	1.78%	1.95%	0.70%	0.74%	0.71%

Drawdowns

DVA vs. FMS - Drawdown Comparison

The maximum DVA drawdown since its inception was -92.91%, which is greater than FMS's maximum drawdown of -77.59%. Use the drawdown chart below to compare losses from any high point for DVA and FMS.

Drawdown Indicators

	DVA	FMS	Difference
Max Drawdown Largest peak-to-trough decline	-92.91%	-77.59%	-15.32%
Max Drawdown (1Y) Largest decline over 1 year	-33.21%	-28.42%	-4.79%
Max Drawdown (5Y) Largest decline over 5 years	-51.10%	-68.85%	+17.75%
Max Drawdown (10Y) Largest decline over 10 years	-51.10%	-75.61%	+24.51%
Current Drawdown Current decline from peak	-13.34%	-53.37%	+40.03%
Average Drawdown Average peak-to-trough decline	-20.14%	-23.61%	+3.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.25%	15.54%	+0.71%

Volatility

DVA vs. FMS - Volatility Comparison

DaVita Inc. (DVA) has a higher volatility of 6.58% compared to Fresenius Medical Care AG & Co. KGaA (FMS) at 6.26%. This indicates that DVA's price experiences larger fluctuations and is considered to be riskier than FMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DVA	FMS	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.58%	6.26%	+0.32%
Volatility (6M) Calculated over the trailing 6-month period	28.09%	20.89%	+7.20%
Volatility (1Y) Calculated over the trailing 1-year period	36.25%	29.29%	+6.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.62%	31.41%	+4.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.76%	29.01%	+4.75%

Financials

DVA vs. FMS - Profitability Comparison

The chart below illustrates the profitability comparison between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported a gross profit of 1.02B and revenue of 3.26B. Therefore, the gross margin over that period was 31.4%.

FMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported a gross profit of 1.39B and revenue of 5.07B. Therefore, the gross margin over that period was 27.4%.

DVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported an operating income of 423.00M and revenue of 3.26B, resulting in an operating margin of 13.0%.

FMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported an operating income of 594.00M and revenue of 5.07B, resulting in an operating margin of 11.7%.

DVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported a net income of 216.00M and revenue of 3.26B, resulting in a net margin of 6.6%.

FMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported a net income of 327.00M and revenue of 5.07B, resulting in a net margin of 6.5%.